The allogeneic response and tumor immunity (Q34269276)

1 August 2017

1 reference

title

The allogeneic response and tumor immunity (English)

1 reference

1 August 2017

Fabre JW

1

1 reference

PubMed ID

11385492

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

6

1 reference

1 August 2017

649-652

1 reference

https://scigraph.springernature.com/pub.10.1038/89008

1 August 2017

0 references

cites work

Cell-Bound Immunity to Autologous and Syngeneic Mouse Tumors Induced by Methylcholanthrene and Plastic Discs

1 reference

7 January 2021

Cellular and Humoral immunity to Different Types of Human Neoplasms

1 reference

7 January 2021

The makings of a tumor rejection antigen

1 reference

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

7 January 2021

The frequency of antigen-sensitive cells in tissue transplantation. A commentary on clonal selection

1 reference

7 January 2021

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

1 reference

7 January 2021

Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

1 reference

7 January 2021

The molecular basis of alloreactivity

1 reference

7 January 2021

Alloreactivity studied with mutants of HLA-A2.

1 reference

7 January 2021

Crystal structure of a T cell receptor bound to an allogeneic MHC molecule

1 reference

7 January 2021

One-way stimulation in mixed leukocyte cultures

1 reference

7 January 2021

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

1 reference

7 January 2021

T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection

1 reference

7 January 2021

Tolerance, danger, and the extended family

1 reference

7 January 2021

1 reference

7 January 2021

Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain

1 reference

7 January 2021

Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts

1 reference

7 January 2021

A THREE-CELL CLUSTER HYPOTHESIS FOR NONCOGNATE T-B COLLABORATION VIA DIRECT T CELL RECOGNITION OF ALLOGENEIC DENDRITIC CELLS1

1 reference

7 January 2021

Mechanisms of Allograft Rejection: The Roles of Cytotoxic T-Cells and Delayed-Type Hypersensitivity

1 reference

7 January 2021

Cells mediating allograft rejection.

1 reference

7 January 2021

Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.

1 reference

7 January 2021

The membrane antigens of human colorectal cancer cells: Demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR

1 reference

7 January 2021

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

7 January 2021

Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides

1 reference

7 January 2021

Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response

1 reference

7 January 2021

Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity

1 reference

7 January 2021

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

7 January 2021

Processing of tumor tissues for vaccination with autologous tumor cells

1 reference

7 January 2021

Adoptive transfer of immunity induced by semi-allogeneic hybrid cells, against a murine fibrosarcoma

1 reference

7 January 2021

Semiallogeneic cell hybrids as therapeutic vaccines for cancer

1 reference

7 January 2021

Semiallogeneic cancer vaccines formulated with granulocyte-macrophage colony-stimulating factor for patients with metastatic gastrointestinal adenocarcinomas: a pilot phase I study

1 reference

7 January 2021

Semi-allogeneic cell hybrids stimulate HIV-1 envelope-specific cytotoxic T lymphocytes

1 reference

7 January 2021

Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions

1 reference

7 January 2021

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

7 January 2021

Reversal of in vitro T cell clonal anergy by IL-2 stimulation

1 reference

7 January 2021

Identifiers

DOI

10.1038/89008

1 reference

1 August 2017

1 reference

PubMed ID

11385492